About the Authors
- Robert A. Kazmierczak
-
* E-mail: KazmierczakR@missouri.edu
Affiliations Cancer Research Center, Columbia, Missouri, United States of America, Division of Biological Sciences, University of Missouri, Columbia, Missouri, United States of America
- Bettina Gentry
-
Affiliation Department of Veterinary Pathobiology, College of Veterinary Medicine, University of Missouri, Columbia, Missouri, United States of America
- Tyler Mumm
-
Affiliations Cancer Research Center, Columbia, Missouri, United States of America, Division of Biological Sciences, University of Missouri, Columbia, Missouri, United States of America
- Heide Schatten
-
Affiliation Department of Veterinary Pathobiology, College of Veterinary Medicine, University of Missouri, Columbia, Missouri, United States of America
- Abraham Eisenstark
-
Affiliations Cancer Research Center, Columbia, Missouri, United States of America, Division of Biological Sciences, University of Missouri, Columbia, Missouri, United States of America
Competing Interests
Authors Robert A. Kazmierczak and Abraham Eisenstark are listed as co-inventors on US patent US8282919 B2 titled "Microorganism Strain CRC2631 of Salmonella typhimurium and its use as a cancer therapeutic". This patent is assigned to the Cancer Research Center (Columbia, MO). Authors Robert A. Kazmierczak and Abraham Eisenstark are employed by the Cancer Research Center and have appointments at the University of Missouri (Columbia, MO). The work in this manuscript was internally funded by the Cancer Research Center. This did not alter the authors' adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: RAK. Performed the experiments: RAK TM. Analyzed the data: RAK BG TM. Contributed reagents/materials/analysis tools: RAK BG AE. Wrote the paper: RAK BG TM HS AE.